APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tacrolimus

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Tacrolimus Market Outlook and Growth Opportunities 2026

20 December 2025217 pages

Choose your research edition.

Industry ResearchTacrolimus Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Tacrolimus Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Tacrolimus Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tacrolimus Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Tacrolimus Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Tacrolimus market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Tacrolimus is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tacrolimus is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tacrolimus is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Tacrolimus market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Tacrolimus market include GSK, Abbott, Takeda, Sichuan Med-Shine Pharmaceutical, Sandoz, Novartis, Mylan, Zhongmei Huadong Pharmaceutical and Hisun Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tacrolimus market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tacrolimus and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tacrolimus sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tacrolimus market size, projected growth trends, production technologies, key applications, and end-use industries.

Tacrolimus Segment by Company

GSK

Abbott

Takeda

Sichuan Med-Shine Pharmaceutical

Sandoz

Novartis

Mylan

Zhongmei Huadong Pharmaceutical

Hisun Pharmaceutical

Yamanouchi Pharmaceutical

Tecoland

Suzhou Pharmaceutical Technology

Squibb

Sinopharm Chuankang Pharmaceutical

Senju Pharmaceutical

ScinoPharm

RPG Life Science

Roche Pharma

Huapont Pharma

Guike Pharmaceutical

Fujisawa Pharmaceutical

Astellas

Accura Pharmaceuticals

Aarti Group

Tacrolimus Segment by Type

Tacrolimus Capsules

Tacrolimus Ointment

Tacrolimus Injection

Tacrolimus Segment by Application

Hospitals

Clinics

Other

Tacrolimus Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Tacrolimus status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Tacrolimus market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Tacrolimus significant trends, drivers, influence factors in global and regions.

6. To analyze Tacrolimus competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tacrolimus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tacrolimus and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tacrolimus.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tacrolimus market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tacrolimus industry.

Chapter 3: Detailed analysis of Tacrolimus manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Tacrolimus in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Tacrolimus in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Tacrolimus Industry Trends Table 2. Tacrolimus Industry Drivers Table 3. Tacrolimus Industry Opportunities and Challenges Table 4. Tacrolimus Industry Restraints Table 5. Global Tacrolimus Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Tacrolimus Revenue Share by Company (2021-2026) Table 7. Global Tacrolimus Sales Volume by Company (K Tons) & (2021-2026) Table 8. Global Tacrolimus Sales Volume Share by Company (2021-2026) Table 9. Global Tacrolimus Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Tacrolimus Company Ranking, (2024-2026) & (USD Million) Table 11. Global Tacrolimus Key Company Manufacturing Base & Headquarters Table 12. Global Tacrolimus Company, Product Type & Application Table 13. Global Tacrolimus Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Tacrolimus by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tacrolimus Capsules Table 18. Significant Companies of Tacrolimus Ointment Table 19. Significant Companies of Tacrolimus Injection Table 20. Global Tacrolimus Sales Volume by Type 2021 VS 2025 VS 2032 (K Tons) Table 21. Global Tacrolimus Sales Volume by Type (2021-2026) & (K Tons) Table 22. Global Tacrolimus Sales Volume by Type (2027-2032) & (K Tons) Table 23. Global Tacrolimus Sales Volume Share by Type (2021-2026) Table 24. Global Tacrolimus Sales Volume Share by Type (2027-2032) Table 25. Global Tacrolimus Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Tacrolimus Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Tacrolimus Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Tacrolimus Sales Value Share by Type (2021-2026) Table 29. Global Tacrolimus Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospitals Table 31. Significant Companies of Clinics Table 32. Significant Companies of Other Table 33. Global Tacrolimus Sales Volume by Application 2021 VS 2025 VS 2032 (K Tons) Table 34. Global Tacrolimus Sales Volume by Application (2021-2026) & (K Tons) Table 35. Global Tacrolimus Sales Volume by Application (2027-2032) & (K Tons) Table 36. Global Tacrolimus Sales Volume Share by Application (2021-2026) Table 37. Global Tacrolimus Sales Volume Share by Application (2027-2032) Table 38. Global Tacrolimus Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Tacrolimus Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Tacrolimus Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Tacrolimus Sales Value Share by Application (2021-2026) Table 42. Global Tacrolimus Sales Value Share by Application (2027-2032) Table 43. Global Tacrolimus Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Table 44. Global Tacrolimus Sales by Region (2021-2026) & (K Tons) Table 45. Global Tacrolimus Sales Market Share by Region (2021-2026) Table 46. Global Tacrolimus Sales by Region (2027-2032) & (K Tons) Table 47. Global Tacrolimus Sales Market Share by Region (2027-2032) Table 48. Global Tacrolimus Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Tacrolimus Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Tacrolimus Sales Value Share by Region (2021-2026) Table 51. Global Tacrolimus Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Tacrolimus Sales Value Share by Region (2027-2032) Table 53. Global Tacrolimus Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global Tacrolimus Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global Tacrolimus Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Table 56. Global Tacrolimus Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Tacrolimus Sales by Country (2021-2026) & (K Tons) Table 58. Global Tacrolimus Sales Market Share by Country (2021-2026) Table 59. Global Tacrolimus Sales by Country (2027-2032) & (K Tons) Table 60. Global Tacrolimus Sales Market Share by Country (2027-2032) Table 61. Global Tacrolimus Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Tacrolimus Sales Value Market Share by Country (2021-2026) Table 63. Global Tacrolimus Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Tacrolimus Sales Value Market Share by Country (2027-2032) Table 65. GSK Company Information Table 66. GSK Business Overview Table 67. GSK Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. GSK Tacrolimus Product Portfolio Table 69. GSK Recent Development Table 70. Abbott Company Information Table 71. Abbott Business Overview Table 72. Abbott Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Abbott Tacrolimus Product Portfolio Table 74. Abbott Recent Development Table 75. Takeda Company Information Table 76. Takeda Business Overview Table 77. Takeda Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. Takeda Tacrolimus Product Portfolio Table 79. Takeda Recent Development Table 80. Sichuan Med-Shine Pharmaceutical Company Information Table 81. Sichuan Med-Shine Pharmaceutical Business Overview Table 82. Sichuan Med-Shine Pharmaceutical Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Sichuan Med-Shine Pharmaceutical Tacrolimus Product Portfolio Table 84. Sichuan Med-Shine Pharmaceutical Recent Development Table 85. Sandoz Company Information Table 86. Sandoz Business Overview Table 87. Sandoz Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Sandoz Tacrolimus Product Portfolio Table 89. Sandoz Recent Development Table 90. Novartis Company Information Table 91. Novartis Business Overview Table 92. Novartis Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. Novartis Tacrolimus Product Portfolio Table 94. Novartis Recent Development Table 95. Mylan Company Information Table 96. Mylan Business Overview Table 97. Mylan Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. Mylan Tacrolimus Product Portfolio Table 99. Mylan Recent Development Table 100. Zhongmei Huadong Pharmaceutical Company Information Table 101. Zhongmei Huadong Pharmaceutical Business Overview Table 102. Zhongmei Huadong Pharmaceutical Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. Zhongmei Huadong Pharmaceutical Tacrolimus Product Portfolio Table 104. Zhongmei Huadong Pharmaceutical Recent Development Table 105. Hisun Pharmaceutical Company Information Table 106. Hisun Pharmaceutical Business Overview Table 107. Hisun Pharmaceutical Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 108. Hisun Pharmaceutical Tacrolimus Product Portfolio Table 109. Hisun Pharmaceutical Recent Development Table 110. Yamanouchi Pharmaceutical Company Information Table 111. Yamanouchi Pharmaceutical Business Overview Table 112. Yamanouchi Pharmaceutical Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 113. Yamanouchi Pharmaceutical Tacrolimus Product Portfolio Table 114. Yamanouchi Pharmaceutical Recent Development Table 115. Tecoland Company Information Table 116. Tecoland Business Overview Table 117. Tecoland Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 118. Tecoland Tacrolimus Product Portfolio Table 119. Tecoland Recent Development Table 120. Suzhou Pharmaceutical Technology Company Information Table 121. Suzhou Pharmaceutical Technology Business Overview Table 122. Suzhou Pharmaceutical Technology Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 123. Suzhou Pharmaceutical Technology Tacrolimus Product Portfolio Table 124. Suzhou Pharmaceutical Technology Recent Development Table 125. Squibb Company Information Table 126. Squibb Business Overview Table 127. Squibb Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 128. Squibb Tacrolimus Product Portfolio Table 129. Squibb Recent Development Table 130. Sinopharm Chuankang Pharmaceutical Company Information Table 131. Sinopharm Chuankang Pharmaceutical Business Overview Table 132. Sinopharm Chuankang Pharmaceutical Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 133. Sinopharm Chuankang Pharmaceutical Tacrolimus Product Portfolio Table 134. Sinopharm Chuankang Pharmaceutical Recent Development Table 135. Senju Pharmaceutical Company Information Table 136. Senju Pharmaceutical Business Overview Table 137. Senju Pharmaceutical Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 138. Senju Pharmaceutical Tacrolimus Product Portfolio Table 139. Senju Pharmaceutical Recent Development Table 140. ScinoPharm Company Information Table 141. ScinoPharm Business Overview Table 142. ScinoPharm Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 143. ScinoPharm Tacrolimus Product Portfolio Table 144. ScinoPharm Recent Development Table 145. RPG Life Science Company Information Table 146. RPG Life Science Business Overview Table 147. RPG Life Science Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 148. RPG Life Science Tacrolimus Product Portfolio Table 149. RPG Life Science Recent Development Table 150. Roche Pharma Company Information Table 151. Roche Pharma Business Overview Table 152. Roche Pharma Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 153. Roche Pharma Tacrolimus Product Portfolio Table 154. Roche Pharma Recent Development Table 155. Huapont Pharma Company Information Table 156. Huapont Pharma Business Overview Table 157. Huapont Pharma Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 158. Huapont Pharma Tacrolimus Product Portfolio Table 159. Huapont Pharma Recent Development Table 160. Guike Pharmaceutical Company Information Table 161. Guike Pharmaceutical Business Overview Table 162. Guike Pharmaceutical Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 163. Guike Pharmaceutical Tacrolimus Product Portfolio Table 164. Guike Pharmaceutical Recent Development Table 165. Fujisawa Pharmaceutical Company Information Table 166. Fujisawa Pharmaceutical Business Overview Table 167. Fujisawa Pharmaceutical Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 168. Fujisawa Pharmaceutical Tacrolimus Product Portfolio Table 169. Fujisawa Pharmaceutical Recent Development Table 170. Astellas Company Information Table 171. Astellas Business Overview Table 172. Astellas Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 173. Astellas Tacrolimus Product Portfolio Table 174. Astellas Recent Development Table 175. Accura Pharmaceuticals Company Information Table 176. Accura Pharmaceuticals Business Overview Table 177. Accura Pharmaceuticals Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 178. Accura Pharmaceuticals Tacrolimus Product Portfolio Table 179. Accura Pharmaceuticals Recent Development Table 180. Aarti Group Company Information Table 181. Aarti Group Business Overview Table 182. Aarti Group Tacrolimus Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 183. Aarti Group Tacrolimus Product Portfolio Table 184. Aarti Group Recent Development Table 185. Key Raw Materials Table 186. Raw Materials Key Suppliers Table 187. Tacrolimus Distributors List Table 188. Tacrolimus Customers List Table 189. Research Programs/Design for This Report Table 190. Authors List of This Report Table 191. Secondary Sources Table 192. Primary Sources List of Figures Figure 1. Tacrolimus Product Image Figure 2. Global Tacrolimus Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tacrolimus Sales Value (2021-2032) & (US$ Million) Figure 4. Global Tacrolimus Sales (2021-2032) & (K Tons) Figure 5. Global Tacrolimus Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Tacrolimus Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tacrolimus Capsules Image Figure 10. Tacrolimus Ointment Image Figure 11. Tacrolimus Injection Image Figure 12. Global Tacrolimus Sales Volume by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 13. Global Tacrolimus Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Tacrolimus Sales Volume Share by Type (2021-2032) Figure 15. Global Tacrolimus Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Tacrolimus Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Tacrolimus Sales Value Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Clinics Image Figure 20. Other Image Figure 21. Global Tacrolimus Sales Volume by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 22. Global Tacrolimus Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Tacrolimus Sales Volume Share by Application (2021-2032) Figure 24. Global Tacrolimus Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Tacrolimus Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Tacrolimus Sales Value Share by Application (2021-2032) Figure 27. Global Tacrolimus Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Figure 28. Global Tacrolimus Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Tacrolimus Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Tacrolimus Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Tacrolimus Sales Value (2021-2032) & (US$ Million) Figure 32. North America Tacrolimus Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Tacrolimus Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Tacrolimus Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Tacrolimus Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Tacrolimus Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Tacrolimus Sales Value (2021-2032) & (US$ Million) Figure 38. South America Tacrolimus Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Tacrolimus Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Tacrolimus Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Tacrolimus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Tacrolimus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Tacrolimus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Tacrolimus Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Tacrolimus Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Tacrolimus Capsules
  • Tacrolimus Ointment
  • Tacrolimus Injection
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • GSK
  • Abbott
  • Takeda
  • Sichuan Med-Shine Pharmaceutical
  • Sandoz
  • Novartis
  • Mylan
  • Zhongmei Huadong Pharmaceutical
  • Hisun Pharmaceutical
  • Yamanouchi Pharmaceutical
  • Tecoland
  • Suzhou Pharmaceutical Technology
  • Squibb
  • Sinopharm Chuankang Pharmaceutical
  • Senju Pharmaceutical
  • ScinoPharm
  • RPG Life Science
  • Roche Pharma
  • Huapont Pharma
  • Guike Pharmaceutical
  • Fujisawa Pharmaceutical
  • Astellas
  • Accura Pharmaceuticals
  • Aarti Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tacrolimus Sales Value (2021-2032)
  4. 1.2.2 Global Tacrolimus Sales Volume (2021-2032)
  5. 1.2.3 Global Tacrolimus Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Tacrolimus Market Dynamics
  1. 2.1 Tacrolimus Industry Trends
  2. 2.2 Tacrolimus Industry Drivers
  3. 2.3 Tacrolimus Industry Opportunities and Challenges
  4. 2.4 Tacrolimus Industry Restraints
3 Tacrolimus Market by Company
  1. 3.1 Global Tacrolimus Company Revenue Ranking in 2025
  2. 3.2 Global Tacrolimus Revenue by Company (2021-2026)
  3. 3.3 Global Tacrolimus Sales Volume by Company (2021-2026)
  4. 3.4 Global Tacrolimus Average Price by Company (2021-2026)
  5. 3.5 Global Tacrolimus Company Ranking (2024-2026)
  6. 3.6 Global Tacrolimus Company Manufacturing Base and Headquarters
  7. 3.7 Global Tacrolimus Company Product Type and Application
  8. 3.8 Global Tacrolimus Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Tacrolimus Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Tacrolimus Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Tacrolimus Market by Type
  1. 4.1 Tacrolimus Type Introduction
  2. 4.1.1 Tacrolimus Capsules
  3. 4.1.2 Tacrolimus Ointment
  4. 4.1.3 Tacrolimus Injection
  5. 4.2 Global Tacrolimus Sales Volume by Type
  6. 4.2.1 Global Tacrolimus Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Tacrolimus Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Tacrolimus Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Tacrolimus Sales Value by Type
  10. 4.3.1 Global Tacrolimus Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Tacrolimus Sales Value by Type (2021-2032)
  12. 4.3.3 Global Tacrolimus Sales Value Share by Type (2021-2032)
5 Tacrolimus Market by Application
  1. 5.1 Tacrolimus Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global Tacrolimus Sales Volume by Application
  6. 5.2.1 Global Tacrolimus Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tacrolimus Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Tacrolimus Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Tacrolimus Sales Value by Application
  10. 5.3.1 Global Tacrolimus Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Tacrolimus Sales Value by Application (2021-2032)
  12. 5.3.3 Global Tacrolimus Sales Value Share by Application (2021-2032)
6 Tacrolimus Regional Sales and Value Analysis
  1. 6.1 Global Tacrolimus Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tacrolimus Sales by Region (2021-2032)
  3. 6.2.1 Global Tacrolimus Sales by Region: 2021-2026
  4. 6.2.2 Global Tacrolimus Sales by Region (2027-2032)
  5. 6.3 Global Tacrolimus Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Tacrolimus Sales Value by Region (2021-2032)
  7. 6.4.1 Global Tacrolimus Sales Value by Region: 2021-2026
  8. 6.4.2 Global Tacrolimus Sales Value by Region (2027-2032)
  9. 6.5 Global Tacrolimus Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Tacrolimus Sales Value (2021-2032)
  12. 6.6.2 North America Tacrolimus Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Tacrolimus Sales Value (2021-2032)
  15. 6.7.2 Europe Tacrolimus Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Tacrolimus Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Tacrolimus Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Tacrolimus Sales Value (2021-2032)
  21. 6.9.2 South America Tacrolimus Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Tacrolimus Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Tacrolimus Sales Value Share by Country, 2025 VS 2032
7 Tacrolimus Country-level Sales and Value Analysis
  1. 7.1 Global Tacrolimus Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Tacrolimus Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Tacrolimus Sales by Country (2021-2032)
  4. 7.3.1 Global Tacrolimus Sales by Country (2021-2026)
  5. 7.3.2 Global Tacrolimus Sales by Country (2027-2032)
  6. 7.4 Global Tacrolimus Sales Value by Country (2021-2032)
  7. 7.4.1 Global Tacrolimus Sales Value by Country (2021-2026)
  8. 7.4.2 Global Tacrolimus Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Tacrolimus Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Tacrolimus Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Tacrolimus Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Tacrolimus Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Tacrolimus Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Tacrolimus Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Tacrolimus Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Tacrolimus Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Tacrolimus Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Tacrolimus Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Tacrolimus Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Tacrolimus Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Tacrolimus Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Tacrolimus Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Tacrolimus Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Tacrolimus Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Tacrolimus Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Tacrolimus Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Tacrolimus Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Tacrolimus Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Tacrolimus Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Tacrolimus Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Tacrolimus Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Tacrolimus Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Tacrolimus Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Tacrolimus Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Tacrolimus Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Tacrolimus Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Tacrolimus Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Tacrolimus Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Tacrolimus Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Tacrolimus Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Tacrolimus Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Tacrolimus Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Tacrolimus Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Tacrolimus Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Tacrolimus Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Tacrolimus Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Tacrolimus Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Tacrolimus Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Tacrolimus Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Tacrolimus Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Tacrolimus Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Tacrolimus Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Tacrolimus Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Tacrolimus Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Tacrolimus Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Tacrolimus Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Tacrolimus Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Tacrolimus Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Tacrolimus Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Tacrolimus Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Tacrolimus Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Tacrolimus Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Tacrolimus Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Tacrolimus Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Tacrolimus Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Tacrolimus Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Tacrolimus Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Tacrolimus Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Tacrolimus Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Tacrolimus Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Tacrolimus Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Tacrolimus Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Tacrolimus Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Tacrolimus Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Tacrolimus Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Tacrolimus Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Tacrolimus Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Tacrolimus Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Tacrolimus Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Tacrolimus Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Tacrolimus Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Tacrolimus Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Tacrolimus Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Tacrolimus Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Tacrolimus Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Tacrolimus Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Tacrolimus Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Tacrolimus Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Tacrolimus Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Tacrolimus Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Tacrolimus Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Tacrolimus Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Tacrolimus Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GSK Tacrolimus Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Abbott
  8. 8.2.1 Abbott Company Information
  9. 8.2.2 Abbott Business Overview
  10. 8.2.3 Abbott Tacrolimus Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Abbott Tacrolimus Product Portfolio
  12. 8.2.5 Abbott Recent Developments
  13. 8.3 Takeda
  14. 8.3.1 Takeda Company Information
  15. 8.3.2 Takeda Business Overview
  16. 8.3.3 Takeda Tacrolimus Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Takeda Tacrolimus Product Portfolio
  18. 8.3.5 Takeda Recent Developments
  19. 8.4 Sichuan Med-Shine Pharmaceutical
  20. 8.4.1 Sichuan Med-Shine Pharmaceutical Company Information
  21. 8.4.2 Sichuan Med-Shine Pharmaceutical Business Overview
  22. 8.4.3 Sichuan Med-Shine Pharmaceutical Tacrolimus Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sichuan Med-Shine Pharmaceutical Tacrolimus Product Portfolio
  24. 8.4.5 Sichuan Med-Shine Pharmaceutical Recent Developments
  25. 8.5 Sandoz
  26. 8.5.1 Sandoz Company Information
  27. 8.5.2 Sandoz Business Overview
  28. 8.5.3 Sandoz Tacrolimus Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sandoz Tacrolimus Product Portfolio
  30. 8.5.5 Sandoz Recent Developments
  31. 8.6 Novartis
  32. 8.6.1 Novartis Company Information
  33. 8.6.2 Novartis Business Overview
  34. 8.6.3 Novartis Tacrolimus Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Novartis Tacrolimus Product Portfolio
  36. 8.6.5 Novartis Recent Developments
  37. 8.7 Mylan
  38. 8.7.1 Mylan Company Information
  39. 8.7.2 Mylan Business Overview
  40. 8.7.3 Mylan Tacrolimus Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Mylan Tacrolimus Product Portfolio
  42. 8.7.5 Mylan Recent Developments
  43. 8.8 Zhongmei Huadong Pharmaceutical
  44. 8.8.1 Zhongmei Huadong Pharmaceutical Company Information
  45. 8.8.2 Zhongmei Huadong Pharmaceutical Business Overview
  46. 8.8.3 Zhongmei Huadong Pharmaceutical Tacrolimus Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Zhongmei Huadong Pharmaceutical Tacrolimus Product Portfolio
  48. 8.8.5 Zhongmei Huadong Pharmaceutical Recent Developments
  49. 8.9 Hisun Pharmaceutical
  50. 8.9.1 Hisun Pharmaceutical Company Information
  51. 8.9.2 Hisun Pharmaceutical Business Overview
  52. 8.9.3 Hisun Pharmaceutical Tacrolimus Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Hisun Pharmaceutical Tacrolimus Product Portfolio
  54. 8.9.5 Hisun Pharmaceutical Recent Developments
  55. 8.10 Yamanouchi Pharmaceutical
  56. 8.10.1 Yamanouchi Pharmaceutical Company Information
  57. 8.10.2 Yamanouchi Pharmaceutical Business Overview
  58. 8.10.3 Yamanouchi Pharmaceutical Tacrolimus Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Yamanouchi Pharmaceutical Tacrolimus Product Portfolio
  60. 8.10.5 Yamanouchi Pharmaceutical Recent Developments
  61. 8.11 Tecoland
  62. 8.11.1 Tecoland Company Information
  63. 8.11.2 Tecoland Business Overview
  64. 8.11.3 Tecoland Tacrolimus Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Tecoland Tacrolimus Product Portfolio
  66. 8.11.5 Tecoland Recent Developments
  67. 8.12 Suzhou Pharmaceutical Technology
  68. 8.12.1 Suzhou Pharmaceutical Technology Company Information
  69. 8.12.2 Suzhou Pharmaceutical Technology Business Overview
  70. 8.12.3 Suzhou Pharmaceutical Technology Tacrolimus Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Suzhou Pharmaceutical Technology Tacrolimus Product Portfolio
  72. 8.12.5 Suzhou Pharmaceutical Technology Recent Developments
  73. 8.13 Squibb
  74. 8.13.1 Squibb Company Information
  75. 8.13.2 Squibb Business Overview
  76. 8.13.3 Squibb Tacrolimus Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Squibb Tacrolimus Product Portfolio
  78. 8.13.5 Squibb Recent Developments
  79. 8.14 Sinopharm Chuankang Pharmaceutical
  80. 8.14.1 Sinopharm Chuankang Pharmaceutical Company Information
  81. 8.14.2 Sinopharm Chuankang Pharmaceutical Business Overview
  82. 8.14.3 Sinopharm Chuankang Pharmaceutical Tacrolimus Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Sinopharm Chuankang Pharmaceutical Tacrolimus Product Portfolio
  84. 8.14.5 Sinopharm Chuankang Pharmaceutical Recent Developments
  85. 8.15 Senju Pharmaceutical
  86. 8.15.1 Senju Pharmaceutical Company Information
  87. 8.15.2 Senju Pharmaceutical Business Overview
  88. 8.15.3 Senju Pharmaceutical Tacrolimus Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Senju Pharmaceutical Tacrolimus Product Portfolio
  90. 8.15.5 Senju Pharmaceutical Recent Developments
  91. 8.16 ScinoPharm
  92. 8.16.1 ScinoPharm Company Information
  93. 8.16.2 ScinoPharm Business Overview
  94. 8.16.3 ScinoPharm Tacrolimus Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 ScinoPharm Tacrolimus Product Portfolio
  96. 8.16.5 ScinoPharm Recent Developments
  97. 8.17 RPG Life Science
  98. 8.17.1 RPG Life Science Company Information
  99. 8.17.2 RPG Life Science Business Overview
  100. 8.17.3 RPG Life Science Tacrolimus Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 RPG Life Science Tacrolimus Product Portfolio
  102. 8.17.5 RPG Life Science Recent Developments
  103. 8.18 Roche Pharma
  104. 8.18.1 Roche Pharma Company Information
  105. 8.18.2 Roche Pharma Business Overview
  106. 8.18.3 Roche Pharma Tacrolimus Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Roche Pharma Tacrolimus Product Portfolio
  108. 8.18.5 Roche Pharma Recent Developments
  109. 8.19 Huapont Pharma
  110. 8.19.1 Huapont Pharma Company Information
  111. 8.19.2 Huapont Pharma Business Overview
  112. 8.19.3 Huapont Pharma Tacrolimus Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Huapont Pharma Tacrolimus Product Portfolio
  114. 8.19.5 Huapont Pharma Recent Developments
  115. 8.20 Guike Pharmaceutical
  116. 8.20.1 Guike Pharmaceutical Company Information
  117. 8.20.2 Guike Pharmaceutical Business Overview
  118. 8.20.3 Guike Pharmaceutical Tacrolimus Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Guike Pharmaceutical Tacrolimus Product Portfolio
  120. 8.20.5 Guike Pharmaceutical Recent Developments
  121. 8.21 Fujisawa Pharmaceutical
  122. 8.21.1 Fujisawa Pharmaceutical Company Information
  123. 8.21.2 Fujisawa Pharmaceutical Business Overview
  124. 8.21.3 Fujisawa Pharmaceutical Tacrolimus Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Fujisawa Pharmaceutical Tacrolimus Product Portfolio
  126. 8.21.5 Fujisawa Pharmaceutical Recent Developments
  127. 8.22 Astellas
  128. 8.22.1 Astellas Company Information
  129. 8.22.2 Astellas Business Overview
  130. 8.22.3 Astellas Tacrolimus Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Astellas Tacrolimus Product Portfolio
  132. 8.22.5 Astellas Recent Developments
  133. 8.23 Accura Pharmaceuticals
  134. 8.23.1 Accura Pharmaceuticals Company Information
  135. 8.23.2 Accura Pharmaceuticals Business Overview
  136. 8.23.3 Accura Pharmaceuticals Tacrolimus Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Accura Pharmaceuticals Tacrolimus Product Portfolio
  138. 8.23.5 Accura Pharmaceuticals Recent Developments
  139. 8.24 Aarti Group
  140. 8.24.1 Aarti Group Company Information
  141. 8.24.2 Aarti Group Business Overview
  142. 8.24.3 Aarti Group Tacrolimus Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 Aarti Group Tacrolimus Product Portfolio
  144. 8.24.5 Aarti Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tacrolimus Value Chain Analysis
  2. 9.1.1 Tacrolimus Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tacrolimus Sales Mode & Process
  6. 9.2 Tacrolimus Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tacrolimus Distributors
  9. 9.2.3 Tacrolimus Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst